STEPHANIE MCCULLOUGH: Open Payments
NPI 1497500995 · ROCKLIN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,516 in 95 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $794 · 2025 $2,516
Food & beverage: $2,516
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $433 |
| AstraZeneca Pharmaceuticals LP | 2 | $230 |
| PFIZER INC. | 5 | $199 |
| GlaxoSmithKline, LLC. | 8 | $173 |
| Inspire Medical Systems, Inc. | 2 | $162 |
| Amgen Inc. | 9 | $147 |
| Lilly USA, LLC | 8 | $144 |
| SI-BONE, INC. | 1 | $137 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $130 |
| GENZYME CORPORATION | 2 | $122 |
Products named: Ozempic, JARDIANCE, INSPIRE, Wegovy, NURTEC ODT, AIRSUPRA, DUPIXENT, EVENITY.
Industry payments across CA — which companies pay providers there.
